James Bs Salazar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James Bs Salazar has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Zian H. Tseng
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA
5 shared publications Ellen Moffatt
Office of Chief Medical Examiner, City and County of San Francisco, San Francisco, California
2 shared publications- Ellen Moffatt
Office of the Chief Medical Examiner, San Francisco, CA
2 shared publications Eric Vittinghoff
Department of Epidemiology and Biostatistics, University of California, San Francisco
2 shared publicationsJeffrey E. Olgin
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California, San Francisco
2 shared publicationsJoanne Probert
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California, San Francisco
2 shared publications
Latest Publications
- 1 June 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (6) , e013809
Fragmented QRS, Arrhythmic Causes, and Myocardial Fibrosis Burden by Autopsy Among Countywide Sudden Deaths
- 1 June 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (6) , e013809
Fragmented QRS, Arrhythmic Causes, and Myocardial Fibrosis Burden by Autopsy Among Countywide Sudden Deaths
- 17 August 2023
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 38 (14) , 3257-3261
Exercises in Clinical Reasoning: Beyond the Surface
- 17 August 2023
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 38 (14) , 3257-3261
Exercises in Clinical Reasoning: Beyond the Surface
- Open Access
- 11 June 2021
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 181 (9) , 1248-1251
Gender, Race, Ethnicity, and Sexual Orientation of Editors at Leading Medical and Scientific Journals
Editors of medical and scientific journals select and develop the research and opinion articles that are published, with important implications for research, patient care, and policy. Despite widespread stated commitments to promote diversity among editorial staff, there is little information about the composition of editorial teams. We developed and administered a survey to assess the diversity of editors at leading medical and scientific journals.
- 11 June 2021
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 181 (9) , 1248-1251
Open AccessGender, Race, Ethnicity, and Sexual Orientation of Editors at Leading Medical and Scientific Journals
Editors of medical and scientific journals select and develop the research and opinion articles that are published, with important implications for research, patient care, and policy. Despite widespread stated commitments to promote diversity among editorial staff, there is little information about the composition of editorial teams. We developed and administered a survey to assess the diversity of editors at leading medical and scientific journals.
- 9 April 2021
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (5) , 491-503
Sex and Racial Differences in Autopsy-Defined Causes of Presumed Sudden Cardiac Death
Background: Sudden cardiac death (SCD) studies report higher incidence in men and Black people but presume cardiac cause. We sought to identify sex and racial differences in rates and causes of presumed SCDs in a prospective postmortem study in San Francisco County. Methods: All incident presumed SCDs meeting the World Health Organization definition ages 18 to 90 were autopsied via active surveillance of consecutive out-of-hospital deaths in the POST SCD study (Postmortem Systematic Investigation of Sudden Cardiac Death; February 1, 2011, to March 1, 2014). Autopsy-defined sudden arrhythmic deaths had no extracardiac cause or acute heart failure. Results: Among 541 presumed SCDs, 525 (97%) were autopsied; 362 (69%) were men, 110 Asian (21%), 81 Black (15%), 40 Hispanic (8%), 279 White (53%), and 15 other race (3%). Adjusted for age and race, women had more noncardiac causes of presumed SCD, including pulmonary emboli (8% versus 2%) and neurological causes (10% versus 3%, both P P =0.02) and nonischemic causes (53% versus 39%; P P P P P , all <0.05). Conclusions: In this countywide postmortem study of presumed SCDs, women had more nonischemic and noncardiac causes. Black women had higher rates of autopsy-defined sudden arrhythmic death than White women while Asian and Hispanic men had lower rates than White men. These findings have implications for risk stratification and prevention of sudden mortality in women and minority populations.
- 9 April 2021
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (5) , 491-503
Sex and Racial Differences in Autopsy-Defined Causes of Presumed Sudden Cardiac Death
Background: Sudden cardiac death (SCD) studies report higher incidence in men and Black people but presume cardiac cause. We sought to identify sex and racial differences in rates and causes of presumed SCDs in a prospective postmortem study in San Francisco County. Methods: All incident presumed SCDs meeting the World Health Organization definition ages 18 to 90 were autopsied via active surveillance of consecutive out-of-hospital deaths in the POST SCD study (Postmortem Systematic Investigation of Sudden Cardiac Death; February 1, 2011, to March 1, 2014). Autopsy-defined sudden arrhythmic deaths had no extracardiac cause or acute heart failure. Results: Among 541 presumed SCDs, 525 (97%) were autopsied; 362 (69%) were men, 110 Asian (21%), 81 Black (15%), 40 Hispanic (8%), 279 White (53%), and 15 other race (3%). Adjusted for age and race, women had more noncardiac causes of presumed SCD, including pulmonary emboli (8% versus 2%) and neurological causes (10% versus 3%, both P P =0.02) and nonischemic causes (53% versus 39%; P P P P P , all <0.05). Conclusions: In this countywide postmortem study of presumed SCDs, women had more nonischemic and noncardiac causes. Black women had higher rates of autopsy-defined sudden arrhythmic death than White women while Asian and Hispanic men had lower rates than White men. These findings have implications for risk stratification and prevention of sudden mortality in women and minority populations.
- 1 December 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (12) , 1687-1688
The Negative U Wave
- 1 December 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (12) , 1687-1688
The Negative U Wave
- Open Access
- 1 October 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (3) , 792-794
Sunset Rounds: a Framework for Post-death Care in the Hospital
- 1 October 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (3) , 792-794
Open AccessSunset Rounds: a Framework for Post-death Care in the Hospital
- Open Access
- 1 October 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (10) , 1400-+
Setting Expectations for Clinical Research During the COVID-19 Pandemic
“Knowing and understanding an epidemic is the first step to defeating it.” Since Tedros Ghebreyesus, PhD, Director-General of the World Health Organization, twe
- 1 October 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (10) , 1400-+
Open AccessSetting Expectations for Clinical Research During the COVID-19 Pandemic
“Knowing and understanding an epidemic is the first step to defeating it.” Since Tedros Ghebreyesus, PhD, Director-General of the World Health Organization, twe
- 1 August 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (8) , 1124-1125
Preserving Access to the Invaluable Clinical Autopsy
As the criterion standard for postmortem diagnosis, clinical autopsy has historically played a vital role in medical advancement—from identifying missed principal causes of death for which treatment likely would have improved survival at a consistent rate of approximately 10% of cases over the past half century1 to refining the definition of sudden cardiac death.2 Thus, autopsy provides crucial insight into both established and emerging diseases, rigorous means for quality assurance and outcomes research, and an important check on our collective premortem diagnostic hubris. However, an array of systems- and individual-level changes has seen autopsy increasingly relegated to relic status. On a systems level, autopsy has been financially disincentivized over the past 30 years, exemplified by the recent decision by the Centers for Medicare & Medicaid Services to eliminate the autopsy program requirement for hospitals to qualify for reimbursement.3 At the individual level, increasing confidence in advanced diagnostic tests has weakened the perceived value of autopsy and negatively biased autopsy discussions that are already uncomfortable for many clinicians. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 August 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (8) , 1124-1125
Preserving Access to the Invaluable Clinical Autopsy
As the criterion standard for postmortem diagnosis, clinical autopsy has historically played a vital role in medical advancement—from identifying missed principal causes of death for which treatment likely would have improved survival at a consistent rate of approximately 10% of cases over the past half century1 to refining the definition of sudden cardiac death.2 Thus, autopsy provides crucial insight into both established and emerging diseases, rigorous means for quality assurance and outcomes research, and an important check on our collective premortem diagnostic hubris. However, an array of systems- and individual-level changes has seen autopsy increasingly relegated to relic status. On a systems level, autopsy has been financially disincentivized over the past 30 years, exemplified by the recent decision by the Centers for Medicare & Medicaid Services to eliminate the autopsy program requirement for hospitals to qualify for reimbursement.3 At the individual level, increasing confidence in advanced diagnostic tests has weakened the perceived value of autopsy and negatively biased autopsy discussions that are already uncomfortable for many clinicians. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 June 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (6) , 898-899
Distinguishing Entities on the J Wave Spectrum
A man in his 70s with a history of hypertension and alcohol use disorder was brought to the hospital unconscious. He had been last seen in his normal state of health 4 days prior. Before arrival, he was noted to be cold with intact pulses. On arrival to the emergency department, the patient was able to localize pain and open his eyes spontaneously but was only able to make incomprehensible sounds; his Glasgow Coma Scale score was 11. Vital signs were notable for severe hypothermia (25.6 °C by urinary catheter, undetectable by rectal thermometer), bradycardia (heart rate, 40/min), and hypotension (blood pressure, 90/40 mm Hg). Physical examination revealed an older adult man, shivering, diffusely cold with diminished but palpable pulses, and evidence of trauma including ecchymoses on his chest and temple. Aside from bradycardia, findings from the cardiac examination were normal. Initial laboratory workup results were notable for metabolic acidosis (pH, 7.24; reference range, 7.35-7.45), mildly elevated troponin level (0.07 ng/mL; reference range, <0.04 ng/mL), markedly elevated creatine kinase level (6350 U/L; reference range, 38-174 U/L), and elevated creatinine level (2.78 mg/dL; reference range, 0.70-1.30 mg/dL). An electrocardiogram (ECG) was obtained (Figure). Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 June 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (6) , 898-899
Distinguishing Entities on the J Wave Spectrum
A man in his 70s with a history of hypertension and alcohol use disorder was brought to the hospital unconscious. He had been last seen in his normal state of health 4 days prior. Before arrival, he was noted to be cold with intact pulses. On arrival to the emergency department, the patient was able to localize pain and open his eyes spontaneously but was only able to make incomprehensible sounds; his Glasgow Coma Scale score was 11. Vital signs were notable for severe hypothermia (25.6 °C by urinary catheter, undetectable by rectal thermometer), bradycardia (heart rate, 40/min), and hypotension (blood pressure, 90/40 mm Hg). Physical examination revealed an older adult man, shivering, diffusely cold with diminished but palpable pulses, and evidence of trauma including ecchymoses on his chest and temple. Aside from bradycardia, findings from the cardiac examination were normal. Initial laboratory workup results were notable for metabolic acidosis (pH, 7.24; reference range, 7.35-7.45), mildly elevated troponin level (0.07 ng/mL; reference range, <0.04 ng/mL), markedly elevated creatine kinase level (6350 U/L; reference range, 38-174 U/L), and elevated creatinine level (2.78 mg/dL; reference range, 0.70-1.30 mg/dL). An electrocardiogram (ECG) was obtained (Figure). Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- Open Access
- 1 May 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (5) , 698-706
Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death
Sudden cardiac death (SCD) is one of the most feared manifestations of cardiovascular disease and is responsible for as many as 5% to 15% of total deaths in the United States.1,2 Heart rate–corrected QT interval prolongation has long been established as an important risk factor for SCD, conveying a 2- to 3-fold increased risk in certain populations.3,4 As such, use of QT interval–prolonging medication (QTPM) has represented a traditional target for prevention of SCD.5 Cautious use of QTPMs has been bolstered by a number of studies linking use of key drug classes such as antipsychotics and antibiotics to SCD.6,7 The collective evidence linking QTPMs and SCD has had lasting clinical and regulatory practice implications, including removal of several QTPMs from the market and the widely adopted practice of routine electrocardiographic monitoring on initiation or increase of a known QTPM regimen.8,9
- 1 May 2020
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (5) , 698-706
Open AccessAssociation of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death
Sudden cardiac death (SCD) is one of the most feared manifestations of cardiovascular disease and is responsible for as many as 5% to 15% of total deaths in the United States.1,2 Heart rate–corrected QT interval prolongation has long been established as an important risk factor for SCD, conveying a 2- to 3-fold increased risk in certain populations.3,4 As such, use of QT interval–prolonging medication (QTPM) has represented a traditional target for prevention of SCD.5 Cautious use of QTPMs has been bolstered by a number of studies linking use of key drug classes such as antipsychotics and antibiotics to SCD.6,7 The collective evidence linking QTPMs and SCD has had lasting clinical and regulatory practice implications, including removal of several QTPMs from the market and the widely adopted practice of routine electrocardiographic monitoring on initiation or increase of a known QTPM regimen.8,9